| 1. |
Naghavi M, Abajobir AA, Abbafati C, et al. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017. The Lancet, 2018, 390(10100): 1151-210.
|
| 2. |
World Health Organization (WHO) Chronic obstructive pulmonary disease (COPD), Fact sheet December 2022 [Internet]. 2022. [cited Sep. 9th, 2022]. Available from: https://www.who.int/en/news-room/fact-sheets/detail/chronic-obstructive-pulmonary-disease-(copd).
|
| 3. |
Burney P, Jarvis D, Perez-Padilla R. The global burden of chronic respiratory disease in adults. Int J Tuberc Lung Dis, 2015, 19(1): 10-20.
|
| 4. |
Weng C, Xu J, Yang L, et al. Prevalence and risk factors of chronic obstructive pulmonary disease in China(the ChinaPulmonary Health [CPH] study): a national cross-sectionalstudy. Lancet, 2018, 391(10131): 1706-1717.
|
| 5. |
Celli BR, Wedzicha JA. Update on Clinical Aspects of Chronic Obstructive Pulmonary Disease. New England Journal of Medicine, 2019, 381(13): 1257-66.
|
| 6. |
Gao JT, Liu YH. Key points of the 2020 WHO global tuberculosis report. J Hebei Med Univ, 2021, 42(1): 1-6.
|
| 7. |
Marks GB, Nguyen NV, Nguyen PTB, et al. Community-wide screening for tuberculosis in a high-prevalence setting. N Engl J Med, 2019, 381(14): 1347-1357.
|
| 8. |
O'Toole RF, Shukla SD, Walters EH. TB meets COPD: An emerging global co-morbidity in human lung disease. Tuberculosis (Edinb). 2015 Dec;95(6): 659-663.
|
| 9. |
Chakrabarti B, Calverley PM, DaviesPD. Tuberculosis and itsincidence, special nature, and relationship with chronicobstructive pulmonary disease. Int J Chron Obstruct PulmonDis, 2007, 2(3): 263-272.
|
| 10. |
中華醫學會呼吸病學分會慢性阻塞性肺疾病學組, 中國醫師協會呼吸醫師分會慢性阻塞性肺疾病工作委員會. 慢性阻塞性肺疾病診治指南(2021年修訂版). 中華結核和呼吸雜志, 2021, 44(3): 170-205.
|
| 11. |
中華醫學會結核病學分會. 肺結核診斷和治療指南. 內科急危重癥雜志, 2002, 8(4): 225-229.
|
| 12. |
中華人民共和國國家衛生和計劃生育委員會. WS 196-2017結核病分類[S/OL]. (2017- 12-12)[2018-02-07]. http: //www. nhfpc. gov. cn/ewebeditor/uploadflle/2017/12/201 71212154717348. pdf.
|
| 13. |
中華人民共和國國家衛生和計劃生育委員會. WS 288-2017肺結核診斷[S/OL]. (2018-01-16)[2018-02-07]. http://www.nhfpe.gov.cn/zwgkzt/s9491/20080l/38801/files/987acb0232964cala9dcf833adl26a31.pdf.
|
| 14. |
黃平. 結核病相關阻塞性肺疾病患者血清炎癥水平及氣道阻塞程度的研究. 青海大學, 2022.
|
| 15. |
van Kampen SC, Wanner A, Edwards M, et al. Internationalresearch and guidelines on post-tuberculosis chronic lungdisorders: a systematic scoping review. BMJ Glob Health, 2018, 3: e000745.
|
| 16. |
萬鵬飛, 徐靜, 陳華萍, 等. 慢性阻塞性肺疾病合并肺結核的臨床特征及危險因素分析. 中華肺部疾病雜志(電子版), 2021, 14(6): 741-744.
|
| 17. |
陳華萍, 胡明冬, 張君國, 等. 慢性阻塞性肺疾病合并癥及其對預后的影響. 解放軍醫學雜志, 2020, 45(8): 834-839.
|
| 18. |
Kamenar K, Hossen S, Gupte AN, et al. Previous tuberculosis disease as a risk factor for chronic obstructive pulmonary disease: a cross-sectional analysis of multicountry, population-based studies. Thorax. 2022;77(11): 1088-1097.
|
| 19. |
宋建奎, 楊紹明, 姚騁, 等. 肺結核合并慢性阻塞性肺疾病流行病學特征. 中國防癆雜志, 2007(4): 370-371.
|
| 20. |
尹洪云, 許家璉. 慢性阻塞性肺病與肺結核的關系. 中國臨床醫生, 2004(8): 12-14.
|
| 21. |
Riza AL, Pearson F, Ugarte-Gil C, et al. Clinical management of concurrent diabetes and tuberculosis and the implications for patient services. Lancet Diabetes Endocrinol, 2014, 2(9): 740-753.
|
| 22. |
周伊南, 朱惠莉. 慢性阻塞性肺疾病合并肺結核的研究進展. 結核與肺部疾病雜志, 2022, 3(4): 338-342.
|
| 23. |
Park HJ, Byun MK, Kim HJ, et al. Histo-ry of pulmonary tuberculosis affects the severity and clinical outcomes of COPD. Respirology, 2018, 23(1): 100-106.
|
| 24. |
Ma L, Gao M. Analysis of Clinical Characteristics and Risk Factors for Drug Resistance in Newly-Treated Patients with Pulmonary Tuberculosis Complicated with Chronic Obstructive Pulmonary Disease. Infect Drug Resist, 2022, 15: 4861-4869.
|
| 25. |
劉盼盼. 慢性阻塞性肺疾病急性加重合并活動性肺結核的臨床特點分析及早期診斷探討. 石河子大學, 2017.
|
| 26. |
尚丹鶴, 喬凱. 慢性阻塞性肺病合并肺結核患者免疫功能變化分析. 河南醫學高等專科學校學報, 2022, 34(3): 278-281.
|
| 27. |
Zavala MJ, Becker GL, Blount RJ. Interrelationships between tuberculosis and chronic obstructive pulmonary disease. Curr Opin Pulm Med, 2023, 29(2): 104-111.
|
| 28. |
賈欽堯, 宋珊, 程耀, 等. 慢性阻塞性肺疾病患者合并肺結核的影響因素分析及其列線圖預測模型的建立. 中國感染與化療雜志, 2023, 23(1): 47-52.
|
| 29. |
L?nnroth K, Williams BG, Cegielski P, et al. A consistent log-linear relationship between tuberculosis incidence and body mass index. Int J Epidemiol, 2010, 39(1): 149-155.
|
| 30. |
Prescott E, Almdal T, Mikkelsen KL, et al. Lange P. Prognostic value of weight change in chronic obstructive pulmonary disease: results from the Copenhagen City Heart Study. Eur Respir J, 2002, 20(3): 539-544.
|
| 31. |
Birlie A, Tesfaw G, Dejene T, Woldemichael K. Time to Death and Associated Factors among Tuberculosis Patients in Dangila Woreda, Northwest Ethiopia. PLOS ONE, 2015, 10(12): e0144244.
|
| 32. |
Collins PF, Stratton RJ, Elia M. Nutritional support in chronic obstructive pulmonary disease: a systematic review and meta-analysis. Am J Clin Nutr, 2012, 95(6): 1385-1395.
|
| 33. |
Sinclair D, Abba K, Grobler L, et al. Nutritional supplements for people being treated for active tuberculosis. Cochrane Database Syst Rev. 2011(11): Cd006086.
|
| 34. |
秦玉姣. 慢性阻塞性肺疾病合并支氣管擴張的臨床特征及相關因素分析. 吉林大學, 2018.
|